.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
US Department of Justice
Accenture
McKesson
Citi
Deloitte
Cerilliant
Merck
Dow
Colorcon

Generated: June 26, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017771

« Back to Dashboard
NDA 017771 describes TECHNELITE, which is a drug marketed by Lantheus Medcl and is included in one NDA. It is available from one supplier. Additional details are available on the TECHNELITE profile page.

The generic ingredient in TECHNELITE is technetium tc-99m sodium pertechnetate generator. There are four drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the technetium tc-99m sodium pertechnetate generator profile page.

Summary for NDA: 017771

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 017771

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TECHNELITE
technetium tc-99m sodium pertechnetate generator
SOLUTION;INTRAVENOUS 017771 NDA Lantheus Medical Imaging, Inc. 11994-090 11994-090-01 1 VIAL in 1 CARTON (11994-090-01) > 12 mL in 1 VIAL
TECHNELITE
technetium tc-99m sodium pertechnetate generator
SOLUTION;INTRAVENOUS 017771 NDA Lantheus Medical Imaging, Inc. 11994-090 11994-090-03 1 VIAL in 1 CARTON (11994-090-03) > 16 mL in 1 VIAL

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SOLUTION;INTRAVENOUSStrength0.0083-2.7 CI/GENERATOR
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;INTRAVENOUSStrength1-20 CI/GENERATOR
Approval Date:Feb 12, 2014TE:RLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Colorcon
Harvard Business School
Express Scripts
McKesson
Cantor Fitzgerald
Novartis
Teva
Dow
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot